Cancer Letters
Volume 319, Issue 1 , Pages 49-55 , 1 June 2012

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

  • Bianca Mostert

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
    • Corresponding Author InformationCorresponding author at: Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands. Tel.: +31 10 704 13 24; fax: +31 10 704 10 05.
  • ,
  • Jaco Kraan

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
  • ,
  • Anieta M. Sieuwerts

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • Petra van der Spoel

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
  • ,
  • Joan Bolt-de Vries

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • Wendy J.C. Prager-van der Smissen

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • Marcel Smid

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • Annemieke M. Timmermans

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • John W.M. Martens

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • Jan W. Gratama

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
  • ,
  • John A. Foekens

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands
  • ,
  • Stefan Sleijfer

      Affiliations

    • Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
    • Erasmus MC, Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Dr. Molenwaterplein 50-60, 3015 GE Rotterdam, Netherlands

Received 10 October 2011 ,Revised 16 December 2011 ,Accepted 16 December 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(11)00790-7

doi: 10.1016/j.canlet.2011.12.031

Cancer Letters
Volume 319, Issue 1 , Pages 49-55 , 1 June 2012